GoodRx Holdings, Inc.

GDRX Healthcare Health Information Services

GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 1.31%, EPS fell 25.0%, free cash flow grew 112.5% and total debt was flat, each against the same quarter a year earlier.

3.36 0.15 −4.27%
Market cap
$1.2B
P/E
62.7×
Fwd P/E
30.9×
Dividend yield
—
F-score
6/9
Altman Z
0.44
Beneish M
−2.40
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

45.39 30.04 30.82 53.73
P/S ratio
1.83 1.21 0.85 1.24
P/FCF ratio
13.98 10.29 6.91 7.42
P/Operating CF
19.30 29.36 56.38 12.09
P/B ratio
2.44 1.57 1.07 1.51
EV/Sales
2.10 1.50 1.17 1.49
EV/EBITDA
10.14 6.83 5.54 7.06
EV/FCF
16.03 12.70 9.52 8.87
Current Ratio
3.11 2.61 1.47 1.38
Net Debt/EBITDA
5.91 4.89 6.94 4.11
Debt/Equity
0.81 0.79 0.78 0.75
Earnings Yield
2.20% 3.33% 3.24% 1.86%
Free Cash Flow Yield
7.15% 9.72% 14.46% 13.48%
Free Cash Flow per Share
0.17 0.05 (0.03) 0.20
Book value per Share
1.73 1.73 1.83 1.91
Free Cash Flow
58.02 17.06 (9.81) 66.42
EV/EBIT
20.27 13.63 11.77 15.58
Other line items

Show all line items

Columns are period end dates